Abstract
BackgroundIt is known from the COMET-trial1 that patients who start Etanercept (ETN) treatment early have a great chance of reaching clinical remission and radiographic non-progression. However, it is still unclear,...
Full Text 
Sign-in/Register to access full text options
Sign-in/Register to access full text options 
Published version (
Free)
Free) 
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a call
